• Latest Posts

Regeneron and Sanofi announce published trial results in children with dermatitis

CHMP recommends approval of Beyfortus for prevention of RSV disease in infants

Sanofi and Regeneron’s Dupixent shows sustained improvement in lung function in children

Sanofi’s first treatment in the U.S. approved for adults and children with ASMD

Hemophilia drug from Sanofi and Sobi has license application accepted for priority review by FDA

Sanofi drops amcenestrant clinical development program


Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence

Success across the board for C4X Discovery Holdings plc and its partnerships

FORTY51 Ventures closes $43M biotech fund and announces first investment

Sanofi sells two portfolios of established products to Neuraxpharma

Study results reveal bleeding episodes are significantly reduced by hemophilia drug

Sanofi Global Health launches 30 nonprofit medicines in low-income countries